Evidence mapPaperPMID 32066973Full record

Trial reportNature medicine2020

Effect of salt substitution on community-wide blood pressure and hypertension incidence.

Antonio Bernabe-Ortiz, Víctor G Sal Y Rosas, Vilarmina Ponce-Lucero, María K Cárdenas, Rodrigo M Carrillo-Larco, Francisco Diez-Canseco, M Amalia Pesantes, Katherine A Sacksteder, Robert H Gilman, J Jaime Miranda

2 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 101 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 9 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01960972 nacompletednot on this map

Launching a Salt Substitute to Reduce Blood Pressure at the Population Level - Peru

TypeinterventionalSponsorUniversidad Peruana Cayetano HerediaRan2014 to 2017Enrolled2,376ConditionsBlood Pressure, HypertensionArmsSalt substitute
NCT07178964 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

The use of potassium-rich salt substitutes in blood pressure control of kidney transplant recipients

TypeinterventionalSponsorUniversity Medical Centre LjubljanaRan2025 to 2026Enrolled80ConditionsHypertension Arterial, Kidney TransplantArmsPotassium-enriched salt-substitute, Regular table salt
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 9 syntheses or guidelines pooled it, 201 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Potassium and the kidney.Nature reviews. Nephrology · 2026
    Review
  19. Review
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Antonio Bernabe-OrtizCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Víctor G Sal Y RosasDepartment of Science, Pontifica Universidad Católica del Perú, Lima, Peru.
Vilarmina Ponce-LuceroCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID http://orcid.org/0000-0002-8439-3096
María K CárdenasCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Rodrigo M Carrillo-LarcoCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Francisco Diez-CansecoCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
M Amalia PesantesCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Katherine A SackstederDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Robert H GilmanDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
J Jaime MirandaCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru. Jaime.Miranda@upch.pe.ORCID http://orcid.org/0000-0002-4738-5468
Universidad Peruana Cayetano Heredia · PEJohns Hopkins University · USPontificia Universidad Católica del Perú · PE

Funding

NHLBI NIH HHS U01 HL114180Wellcome Trust 214185Wellcome Trust (Wellcome) 103994/Z/14/Z
6 · The paper itself

Abstract

Replacement of regular salt with potassium-enriched substitutes reduces blood pressure in controlled situations, mainly among people with hypertension. We report on a population-wide implementation of this strategy in a stepped-wedge cluster randomized trial (NCT01960972). The regular salt in enrolled households was retrieved and replaced, free of charge, with a combination of 75% NaCl and 25% KCl. A total of 2,376 participants were enrolled in 6 villages in Tumbes, Peru. The fully adjusted intention-to-treat analysis showed an average reduction of 1.29 mm Hg (95% confidence interval (95% CI) (-2.17, -0.41)) in systolic and 0.76 mm Hg (95% CI (-1.39, -0.13)) in diastolic blood pressure. Among participants without hypertension at baseline, in the time- and cluster-adjusted model, the use of the salt substitute was associated with a 51% (95% CI (29%, 66%)) reduced risk of developing hypertension compared with the control group. In 24-h urine samples, there was no evidence of differences in sodium levels (mean difference 0.01; 95% CI (0.25, -0.23)), but potassium levels were higher at the end of the study than at baseline (mean difference 0.63; 95% CI (0.78, 0.47)). Our results support a case for implementing a pragmatic, population-wide, salt-substitution strategy for reducing blood pressure and hypertension incidence.

Indexed as

Residence CharacteristicsAdultBlood PressureCase-Control StudiesDiastoleFemaleFollow-Up StudiesHumansHypertensionIncidenceMalePeruPotassiumSodiumSodium Chloride, DietarySurveys and QuestionnairesPotassiumSodiumSodium Chloride, Dietary

Identifiers

PMID32066973
PMCPMC7613083
OpenAlexW3006079519

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.